Elironrasib May Overcome Resistance to Prior KRAS G12C Inhibition in Non-small Cell Lung Cancer
The small molecule KRAS inhibitor elironrasib targets the active GTP-bound form of KRAS G12C and led to encouraging responses...
The small molecule KRAS inhibitor elironrasib targets the active GTP-bound form of KRAS G12C and led to encouraging responses...
BOSTON – FX-909, a first-in-class investigational oral small molecule inhibitor of peroxisome proliferator-activated receptor gamma (PPARG), showed early signs...
BOSTON – Zenocutuzumab (Bizengri), a bispecific antibody that targets human epidermal growth factor receptor 2 (HER2) and HER3, led...
Patients with brain metastasis experienced responses in the phase I clinical trial BOSTON – Zocilurtatug pelitecan (zoci), also known as ZL-1310, an...
Social risks include insecure access to living essentials and affordable health care, as well as psychological issues BALTIMORE –...
BALTIMORE – The incidence of obesity-associated cancers in Puerto Rico rose significantly between 2000 and 2022, according to research...
An HPV self-sampling option vastly increased engagement in cervical cancer screening among Korean, Vietnamese, and Chinese women in the...
The $1 million prize will be presented at the AACR Special Conference on Advances in Pancreatic Cancer Research later...
Female cancer survivors were 69% more likely to experience cancer-related fatigue and 58% more likely to experience depression than...
Treatment guided by both tests led to better outcomes than standard of care CHICAGO – Patients with advanced solid...